Home > Insider Trading > Filing (0001415889-24-007534)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1798749	Aerovate Therapeutics Inc.	AVTE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413006	A George Eldridge	C/O Aerovate Therapeutics, Inc. 930 Winter Street, Suite M-500 Waltham MA 02451	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-03-07	22,386	$2.14	24,346	No	4	M	Direct
Common Stock	Disposition	2024-03-07	22,386	$25.00	1,960	No	4	S	Direct
Common Stock	Acquisiton	2024-03-08	114	$2.14	2,074	No	4	M	Direct
Common Stock	Disposition	2024-03-08	114	$25.00	1,960	No	4	S	Direct
Common Stock	Acquisiton	2024-03-11	3,433	$2.14	5,393	No	4	M	Direct
Common Stock	Disposition	2024-03-11	3,423	$25.24	1,970	No	4	S	Direct
Common Stock	Disposition	2024-03-11	10	$26.31	1,960	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-03-07	1,400	$0.00	1,400	$2.14
Common Stock	Stock Option (Right to Buy)	Disposition	2024-03-07	20,986	$0.00	20,986	$2.14
Common Stock	Stock Option (Right to Buy)	Disposition	2024-03-08	114	$0.00	114	$2.14
Common Stock	Stock Option (Right to Buy)	Disposition	2024-03-11	3,433	$0.00	3,433	$2.14

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,263	2031-04-01	No	4	M	Direct
58,877	2031-04-01	No	4	M	Direct
58,763	2031-04-01	No	4	M	Direct
55,330	2031-04-01	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.289, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.88, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.